Literature DB >> 32458485

Effects of methylation of deiodinase 3 gene on gene expression and severity of Kashin-Beck disease.

Zhaofang Li1, Di Zhang1, Qiang Li1, Xiaoli Yang1, Rongqiang Zhang1, Dandan Zhang1, Xuena Yang1, Chen Wang1, Xiwang Tan1, Yongmin Xiong1.   

Abstract

Kashin-Beck disease (KBD) is a complex endemic osteoarthropathy, which mainly occurs in the northeast to southwest China. Iodothyronine deiodinases 3 (DIO3) is one of the selenoproteins, which is closely related to bone metabolism and unclear to KBD. This study aims to investigate the role and associated mechanisms of methylation and expression of DIO3 with disease severity in patients with KBD. We performed a bioinformatics analysis first to identify the biological mechanisms involved in selenoproteins. The methylation status of the DIO3 gene and DIO3 gene expression, as well as DIO3-related regulatory genes in patients with KBD, were analyzed. We found that 15 CpG sites of six selenoproteins were hypomethylated with 5-azacytidine treatment. DIO3 hypermethylation was associated with an increased risk of KBD and may lead to downregulation of DIO3 gene expression as well as be an indicator of the severity of KBD, which may provide a new insight for gene-environment correlations and interactions in etiology and pathogenesis of KBD.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  DNA methylation; Kashin-Beck disease; bioinformatics; deiodinase 3

Mesh:

Substances:

Year:  2020        PMID: 32458485     DOI: 10.1002/jcp.29809

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  1 in total

1.  Dysregulation of Transcription Profile of Selenoprotein in Patients with Kashin-Beck Disease and Its Effect on Se Deficiency-Induced Chondrocyte Apoptosis.

Authors:  XiaoLi Yang; ZhaoFang Li; RongQiang Zhang; Di Zhang; YongMin Xiong; Chen Wang; XueNa Yang; Qiang Li
Journal:  Biol Trace Elem Res       Date:  2021-06-26       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.